Irvine, CA, United States of America

Mohammed Arif Iftekhar


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mohammed Arif Iftekhar: Innovator in Endovascular Treatment

Introduction

Mohammed Arif Iftekhar is a notable inventor based in Irvine, California. He has made significant contributions to the field of medical technology, particularly in the treatment of aortic aneurysms. His innovative approach has the potential to improve patient outcomes and reduce complications associated with endovascular procedures.

Latest Patents

Iftekhar holds a patent for a method titled "Modulation of inflammatory response following endovascular treatment." This patent describes a technique for treating aortic aneurysms using an endovascular graft system. The method involves placing a prosthesis across the aneurysmal space, which consists of a double-walled filling structure and a stent-graft. The stent-graft is expanded at a specific pressure, and a filling agent is used to interact with the thrombus in the aneurysmal space. This innovative approach aims to mitigate post-implant syndrome associated with the prosthesis.

Career Highlights

Iftekhar is currently employed at Endologix, Inc., where he continues to develop and refine medical technologies. His work focuses on enhancing the safety and efficacy of endovascular treatments. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the medical field.

Collaborations

Iftekhar has collaborated with notable colleagues, including Peter Costandi and Carlos Ortega. These partnerships have fostered innovation and advancement in the medical technology sector.

Conclusion

Mohammed Arif Iftekhar is a pioneering inventor whose work in endovascular treatment is making a significant impact in the medical field. His innovative methods and collaborations are paving the way for improved patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…